Delivery Order SPE2DB24D1021-SPE2DB25FEVVQ
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVL89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,472.54 delivery order contract is for the supply of 4,568,077,928 vials of the medication Remifentanil 2 mg. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 2 mg vials of the medication Remifentanil, with a ceiling value of $1,676.23 and a period of performance through July 1, 2025. The contract is a firm fixed-price, non-set-aside award, meaning it was open to full and open competition. AmerisourceBergen Drug Corporation...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $9,081.40 firm fixed price contract is for the supply of 1 mg vials of the drug remifentanil. The contract has a completion date of February 7, 2025 and was awarded on February 6, 2025. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,667.20 firm fixed-price delivery order is for the supply of 1 mg vials of the medication Remifentanil. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Remifentanil 1 mg vials, a specialty medication. The fixed-price delivery order has a ceiling value of $3,632.56 and a completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 2 mg vials of the medication Remifentanil. The contract has a firm fixed price of $3,039.11 and a completion date of June 6, 2025. The contract is not set-aside and was awarded on June 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,489.05 contract is for the delivery of Remifentanil 5 mg vials, with a period of performance ending on June 30, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This contract award is a delivery order worth $5,696.14 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Remifentanil 1 mg vials, a specialty medication used for pain management. The contract has an ultimate completion date of November 28, 2023 and is a firm fixed price arrangement. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,380.66, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical's Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the delivery of REMIFENTANIL 1 MG VIALS to support military healthcare programs. The award has no set-aside designation, indicating open competition....
This federal contract award, identified as SPE2DB22D2007|SPE2DB25FJ1FR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.52 delivery order contract is for the supply of 4,568,142,295 units of the drug Remifentanil 1 mg vials. The contract is a firm fixed-price, non-set-aside arrangement with a performance period extending through May 6, 2025. AmerisourceBergen Drug Corp holds a...